Trial Profile
Prospective, randomized, double-blind trial of abrupt and tapered interruption of long-term clopidogrel therapy after implantation of a drug-eluting stent.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 29 Jul 2016
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary)
- Indications Cardiovascular disorders
- Focus Therapeutic Use
- Acronyms ISAR-CAUTION
- 08 Feb 2014 Status changed from active, no longer recruiting to discontinued.
- 11 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 04 Jan 2012 Planned end date changed from 1 Jun 2011 to 1 Jul 2012 as reported by ClinicalTrials.gov.